# Polaryx Therapeutics, Inc.: Form 8-K, filed Sep 1, 2026

- Company: [Polaryx Therapeutics, Inc.](/companies/plyx.md) (CIK 2075320)
- Form: 8-K
- Filed: 2026-09-01
- Accepted by EDGAR: Sep 1, 2026, 16:30 ET
- Period: 2026-09-01
- Accession: 0001213900-26-096235
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2075320/000121390026096235/ea0303928-8k_polaryx.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2075320/000121390026096235/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2075320/000121390026096235/ea0303928-8k_polaryx.htm

Filed Sep 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-096235. Last ingested by Listed: Nov 13, 2026, 15:59 ET. No prices; not investment advice.
